NCT06974110 2026-01-16
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
Shandong Cancer Hospital and Institute
City of Hope Medical Center
Anhui Provincial Hospital
Persephone Biosciences
Beijing Chao Yang Hospital